COVID-19/SARS-CoV-2 test volumes have now settled to some extent from the latest test surge due to the community outbreak of the Delta variant. However, COVID-19 test numbers remain elevated and further surges notwithstanding, are likely to continue at increased levels for the foreseeable future.
Normal requesting patterns can now be resumed (including samples for mycobacterial culture following the recent cyberattack at Waikato Hospital).
Pathlab ask practices to please strictly adhere to “Choosing wisely” requesting principles and closely adhere to the clinical detail requirements as outlined on the Pathlab website. They ask you please consider carefully whether the laboratory request is likely to have a significant impact on patient management before sending them a sample.
Note that in the event of a further surge in COVID-19/SARS-CoV-2 test numbers, Pathlab will be required to re-implement further testing restrictions with immediate effect.
Thank you for your cooperation during this challenging time. Reduced test volumes for non-COVID-19 microbiology testing has allowed Pathlab to divert resources and maintain fast turnaround times for COVID-19 PCR testing during the recent testing surge. This is very much appreciated as they try and minimise the pressure on their laboratory staff and maintain good turnaround times and test quality for all the assays they perform.
Read this Pathlab clinical update here (PDF).